Comparable outcomes in chronic lymphocytic leukaemia (CLL) patients treated with reduced‐dose ibrutinib: results from a multi‐centre study. (21st February 2017) - Mato, Anthony R.; Timlin, Colleen; Ujjani, Chaitra; Skarbnik, Alan; Howlett, Christina; Banerjee, Rahul; Nabhan, Chadi; Schuster, Stephen J.